Clinical trial
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the…
NCT00282763 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00282763 |
|---|---|
| Title | A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005) |
| Official title | Proprietary Information - Exploratory (Non-confirmatory) Trial |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuralgia, Postherpetic |
| Intervention type | Drug |
| Interventions | MK0686 |
| Enrollment | 12 |
| Start date | Dec 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jan 27, 2006 |
| Last update posted | Nov 23, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: